Investment in R&D for neglected diseases delivers an outstanding societal return on investment

Policy Cures Research today releases a landmark report quantifying, for the first time, the impact of the last two decades of global investment in research and development for neglected diseases. The two-year project, using PCR’s G-FINDER funding data, a newly developed database of pipeline candidates in infectious diseases and sophisticated modelling, shows that investing in global health product R&D pays off, yielding a staggering health and economic return to societies of $405 for every $1 invested.